[1]
A. Pareek, S. Nikam, and R. Akolekar, “Is intervening inflammatory pathways a way to treat type 2-diabetes”, Int J Basic Clin Pharmacol, vol. 14, no. 3, pp. 441–450, Apr. 2025.